Thank you, Mr. Chair.
Thank you to our witnesses.
We passed this bill in the House, and then it was sent to the committee. Our committee's intention is always to improve bills. There are probably some gaps in the natural health products bill. We know very well that it is essential for these products to be accessible and for the industry to continue to prosper. All of these things are important, but we have to look at the gaps.
You all mentioned problems, especially with nicotine products. That needs to be taken into consideration, as Mr. Thériault said. He raised the fact that we were considering making amendments to improve the bill.
Ms. Doucas, I would like to come back to two points you raised in your remarks. Thank you, by the way, for being here today.
You mentioned the approval of Zonnic in July 2023. Could you tell me if there was any consultation before the product was approved?
You also mentioned that the tobacco industry often says that nicotine is not problematic. Could you briefly talk about all the negative health effects of nicotine?